Search Results - "glucose"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    O-GlcNAc, an essential regulator of numerous cellular pathways

    Published 2014
    Subjects:
    Get full text
    Series
    Electronic Video
  2. 2

    Transporters in drug delivery

    Published 2022
    Table of Contents: “…Contents: Biotransporters in drug delivery -- Classification of transporters -- P-glycoprotein transporters -- Transporters for cancer therapy -- Solute carrier transporters -- Facilitative glucose transporters -- The substrates and inhibitors of different transporters -- Effect of transporters in drug delivery -- Pharmacological applications.…”
    Get full text
    Series
    Electronic Video
  3. 3

    Transporters in drug delivery

    Published 2022
    Table of Contents: “…Contents: Biotransporters in drug delivery -- Classification of transporters -- P-glycoprotein transporters -- Transporters for cancer therapy -- Solute carrier transporters -- Facilitative glucose transporters -- The substrates and inhibitors of different transporters -- Effect of transporters in drug delivery -- Pharmacological applications.…”
    Get full text
    Series
    Electronic Video
  4. 4

    O-GlcNAc, an essential regulator of numerous cellular pathways

    Published 2014
    Subjects:
    Get full text
    Series
    Electronic Video
  5. 5

    O-GlcNAc, an essential regulator of numerous cellular pathways

    Published 2014
    Subjects:
    Get full text
    Series
    Electronic Video
  6. 6

    Roles of AMPK in energy homeostasis and nutrient sensing

    Published 2021
    Subjects:
    Get full text
    Series
    Electronic Video
  7. 7

    Roles of AMPK in energy homeostasis and nutrient sensing

    Published 2021
    Subjects:
    Get full text
    Series
    Electronic Video
  8. 8

    PI3K/AKT signaling In cancer

    Published 2011
    Table of Contents: “…Contents: PI3K/AKT signal transduction pathway -- Tumors with frequent dysregulation of PI3K signalling -- Modalities for inhibiting PI3K-AKT signaling currently in development -- AKT1/2 inhibitor (Merck) -- PI3K/AKT in breast cancer -- AKTi-1/2 inhibits AKT signaling and causes G1 arrest -- The Herceptin-resistant -- Effect of AKT inhibition on glucose levels -- Mutated elements in mitogenic signaling pathways in tumors -- Coexistent K-Ras or B-Raf mutation -- Genes encoding several components of mitogenic signaling pathways are mutationally activated in tumors -- Integrators of multiple signaling pathways (OR-gates) -- The effects of combined inhibition of AKT and MAPK on the phosphorylation of translational regulatory proteins -- Knockdown of 4EBP1 expression -- Feedback inhibition of insulin/IGF-1 signaling -- The concept of feedback -- Clinical effects of Rapamycin-like drugs -- mTORC1 vs. …”
    Get full text
    Series
    Electronic Video
  9. 9

    PI3K/AKT signaling In cancer

    Published 2011
    Table of Contents: “…Contents: PI3K/AKT signal transduction pathway -- Tumors with frequent dysregulation of PI3K signalling -- Modalities for inhibiting PI3K-AKT signaling currently in development -- AKT1/2 inhibitor (Merck) -- PI3K/AKT in breast cancer -- AKTi-1/2 inhibits AKT signaling and causes G1 arrest -- The Herceptin-resistant -- Effect of AKT inhibition on glucose levels -- Mutated elements in mitogenic signaling pathways in tumors -- Coexistent K-Ras or B-Raf mutation -- Genes encoding several components of mitogenic signaling pathways are mutationally activated in tumors -- Integrators of multiple signaling pathways (OR-gates) -- The effects of combined inhibition of AKT and MAPK on the phosphorylation of translational regulatory proteins -- Knockdown of 4EBP1 expression -- Feedback inhibition of insulin/IGF-1 signaling -- The concept of feedback -- Clinical effects of Rapamycin-like drugs -- mTORC1 vs. …”
    Get full text
    Series
    Electronic Video
  10. 10

    PI3K/AKT signaling In cancer

    Published 2011
    Table of Contents: “…Contents: PI3K/AKT signal transduction pathway -- Tumors with frequent dysregulation of PI3K signalling -- Modalities for inhibiting PI3K-AKT signaling currently in development -- AKT1/2 inhibitor (Merck) -- PI3K/AKT in breast cancer -- AKTi-1/2 inhibits AKT signaling and causes G1 arrest -- The Herceptin-resistant -- Effect of AKT inhibition on glucose levels -- Mutated elements in mitogenic signaling pathways in tumors -- Coexistent K-Ras or B-Raf mutation -- Genes encoding several components of mitogenic signaling pathways are mutationally activated in tumors -- Integrators of multiple signaling pathways (OR-gates) -- The effects of combined inhibition of AKT and MAPK on the phosphorylation of translational regulatory proteins -- Knockdown of 4EBP1 expression -- Feedback inhibition of insulin/IGF-1 signaling -- The concept of feedback -- Clinical effects of Rapamycin-like drugs -- mTORC1 vs. …”
    Get full text
    Series
    Electronic Video